drugset
drugset / Trial / NCT00653003

Bioavailability Study of Leflunomide Tablets Under Fed Conditions

NCT00653003 ↗

Phase 1 Completed 62 enrolled Par Pharmaceutical, Inc. Novum Pharmaceutical Research Services · collab
RandomizedCrossoverOpen-labelOther

Summary

To compare the single-dose Bioavailability of Kali and Aventis

Timeline

Start
2003-12
Primary completion
2004-01
Completion
2004-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Leflunomide Small molecule 20 mg —

Indications

No indication recorded.